	US 12,383,527 B2
	Methods for treating triple negative breast cancer using salvianolic acid B
Xinbin Gu, Washington, DC (US)
Assigned to Howard University, Washington, DC (US)
Filed by HOWARD UNIVERSITY, Washington, DC (US)
Filed on Feb. 13, 2024, as Appl. No. 18/439,896.
Application 18/439,896 is a division of application No. 17/046,577, previously published as PCT/US2019/027029, filed on Apr. 11, 2019.
Claims priority of provisional application 62/656,204, filed on Apr. 11, 2018.
Prior Publication US 2024/0180867 A1, Jun. 6, 2024
Int. Cl. A61K 31/343 (2006.01); A61K 31/704 (2006.01); A61P 35/00 (2006.01)

CPC A61K 31/343 (2013.01) [A61K 31/704 (2013.01); A61P 35/00 (2018.01)]

8 Claims

1. A method of treating triple-negative breast cancer in a subject in need thereof, the method comprising administering a therapeutically effective amount of salvianolic acid B or a pharmaceutically acceptable salt or solvate thereof to the subject,

wherein the subject is a human.